Fosun International LTD Beyond Spring Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$11.21 - $18.15 $1.74 Million - $2.82 Million	-155,564 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$9.68 - $18.47 $226,115 - $431,440	-23,359 Reduced 13.06%	155,564 $1.99 Million
Q3 2019 Nov 12, 2019	SELL	$15.33 - $23.85 $936,310 - $1.46 Million	-61,077 Reduced 25.45%	178,923 $3.24 Million
Q3 2017 Nov 14, 2017	BUY	$35.55 - $41.28 $8.53 Million - $9.91 Million	240,000	240,000 $8.85 Million

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.